FDA Inspection 1231026 — Penta International Corp
The FDA completed an inspection of Penta International Corp on February 16, 2024 in West Caldwell, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- West Caldwell, NJ (United States)